Recently, magnolol has been found to have anti-allergic effects on allergic rhinitis via the inhibition of ORAI1 (calcium release-activated calcium channel protein 1) and ANO1 (a calcium-activated anion channel 1) channels (Phan et al., 2022). Here, ORAI1 is linked to allergic rhinitis.